he osteoarthritis therapeutics market, valued at USD 9.13 billion in 2023, is driven by factors such as the increasing prevalence of osteoarthritis, particularly among the aging population, and advancements in treatment
he osteoarthritis therapeutics market, valued at USD 9.13 billion in 2023, is driven by factors such as the increasing prevalence of osteoarthritis, particularly among the aging population, and advancements in treatment